Medicine News and Research

RSS

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.

6 Oct 2009

Scientists expand their fleet of genomic next-generation sequencing technology to study about cancer

Scientists from the Baylor College of Medicine Human Genome Sequencing Center (HGSC) are expanding their fleet of advanced genomic next-generation sequencing technology from Applied Biosystems, part of Life Technologies Corporation to accelerate their studies of the genetic underpinnings of cancer and other complex human diseases.

6 Oct 2009

Ground Zero Pharmaceuticals opens new office in Brisbane

A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.

6 Oct 2009

Hepatitis B Foundation calls for consistent monitoring and referral of HBV infected children

An expert panel of nationally recognized pediatric liver specialists convened by the Hepatitis B Foundation is calling for more consistent monitoring and referral of children chronically infected with the hepatitis B virus (HBV). The panel's recommendations for pediatricians and other primary care practitioners stress the need for routine monitoring of children with chronic HBV infections, and timely consultation with a pediatric liver specialist.

6 Oct 2009

Kennedy Krieger Institute announces the results of largest ever twin study of ASDs

Kennedy Krieger Institute announced today new study results from the largest ever twin study that confirm the role genetics plays in autism spectrum disorders (ASDs), but also suggest that environmental factors play a role.

6 Oct 2009

Next generation remote monitoring platform to improve healthcare access

UPMC Health Plan today announced a joint initiative with BL Healthcare to address the issues of access to quality healthcare and rising healthcare costs by using technology to provide remote care over broadband. UPMC Health Plan will leverage BL Healthcare's next generation remote monitoring platform to provide unique and innovative services to their members.

6 Oct 2009

Researchers find increase in the number of procedures performed for dermatologic health care

Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. The findings, which were recently reported in Dermatologic Surgery, parallels the growth in the age of individuals between the ages of 40 to 55, who make up the "Baby Boomer" generation.

6 Oct 2009

Ingenuity Systems, Millennium Science announce a multi-year deal for Ingenuity Pathway Analysis with QFAB

Ingenuity Systems, the leading provider of information solutions for life science researchers, and Millennium Science, Ingenuity Systems' exclusive distributor for Australia and New Zealand, today announced a multi-year deal for Ingenuity Pathway Analysis (IPA) with the Queensland Facility for Advanced Bioinformatics (QFAB).

6 Oct 2009

HIV prevalence high among African Americans

HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.

6 Oct 2009

Over 23 percent of physicians are e-prescribing, Surescripts announces

Surescripts, The Nation's E-Prescription Network, today announced that more than 140,000 (23 percent) of all office-based physicians, nurse practitioners and physician assistants in the United States are now e-prescribing. At the current pace, Surescripts projects that its total number of active e-prescribers in 2009 will more than double the 74,000 active e-prescribers at the end of 2008.

6 Oct 2009

Premera Blue Cross supports cancer diagnostics study

Premera Blue Cross applauds today’s announcement by researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute, and the University of Washington Schools of Public Health and Pharmacy.

6 Oct 2009

UCSF's Elizabeth Blackburn receives Nobel Prize in Medicine, lauded by Speaker Nancy Pelosi

Speaker Nancy Pelosi issued the following statement congratulating molecular biologist Elizabeth H. Blackburn of the University of California, San Francisco, who today was named to receive the 2009 Nobel Prize in Medicine. Dr. Blackburn shares the award with Carol W. Greider of Johns Hopkins University School of Medicine and Jack W. Szostak of Harvard Medical School for their discovery of an enzyme that plays a key role in normal cell function, as well as in cell aging and most cancers.

6 Oct 2009

Keiser University launches its new Master of Science degree in P.A. program

Keiser University's Graduate School is pleased to announce its new Master of Science degree in Physician Assistant (P. A.) program. The university has been awarded provisional accreditation by the Accreditation Review Commission on Education for the Physician Assistant (ARC-PA).

6 Oct 2009

Emergency Ultrasound Consultants, TSG collaborate to reduce medical errors

Emergency Ultrasound Consultants, LLC (EUC), the experts in point-of-care ultrasound education and quality assurance solutions, announced today a strategic partnership with The Sullivan Group (TSG), a world leading provider of patient safety, risk management and performance improvement solutions for healthcare professionals.

6 Oct 2009

Vivaldi receives US patent for live attenuated influenza vaccines

Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.

6 Oct 2009

Boston Scientific begins patient enrollments for MADIT-RIT clinical trial

Boston Scientific Corporation today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new trial follows in the tradition of three previous landmark trials: MADIT, MADIT II and MADIT-CRT, each exclusively sponsored by Boston Scientific and conducted under the leadership of Principal Investigator Arthur J. Moss, M.D., Professor of Medicine at the University of Rochester.

6 Oct 2009

Researchers identify novel circulation within human eye that provides new insight into glaucoma

Researchers at the University of Toronto, St. Michael's Hospital and Sunnybrook Health Sciences Centre have discovered a previously unidentified form of circulation within the human eye which may provide important new insights into glaucoma, a leading cause of blindness.

6 Oct 2009

Tianyin Pharmaceutical declares quarterly cash dividend to common stock shareholders

Tianyin Pharmaceutical Co. Inc. (NYSE Amex: TPI), a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today declared a quarterly cash dividend to be paid to its common stock shareholders.

6 Oct 2009

Survival rates for multivisceral transplants increase with new treatment strategies

Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management, said researchers at the Thomas E. Starzl Transplantation Institute in a study published in the October issue of Annals of Surgery.

6 Oct 2009

Emergency preparedness and business continuity planning to prevent and manage H1N1 virus

This fall the CDC estimates that upwards of 50 percent of Americans could come down with the H1N1 virus, killing as many as 1.2 million people. Additionally, there are estimates that many companies will experience between 30-50 percent absenteeism due to employee illness.

6 Oct 2009

Medicine News and Research

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Scientists expand their fleet of genomic next-generation sequencing technology to study about cancer

Ground Zero Pharmaceuticals opens new office in Brisbane

Hepatitis B Foundation calls for consistent monitoring and referral of HBV infected children

Kennedy Krieger Institute announces the results of largest ever twin study of ASDs

Next generation remote monitoring platform to improve healthcare access

Researchers find increase in the number of procedures performed for dermatologic health care

Ingenuity Systems, Millennium Science announce a multi-year deal for Ingenuity Pathway Analysis with QFAB

HIV prevalence high among African Americans

Over 23 percent of physicians are e-prescribing, Surescripts announces

Premera Blue Cross supports cancer diagnostics study

UCSF's Elizabeth Blackburn receives Nobel Prize in Medicine, lauded by Speaker Nancy Pelosi

Keiser University launches its new Master of Science degree in P.A. program

Emergency Ultrasound Consultants, TSG collaborate to reduce medical errors

Vivaldi receives US patent for live attenuated influenza vaccines

Boston Scientific begins patient enrollments for MADIT-RIT clinical trial

Researchers identify novel circulation within human eye that provides new insight into glaucoma

Tianyin Pharmaceutical declares quarterly cash dividend to common stock shareholders

Survival rates for multivisceral transplants increase with new treatment strategies

Emergency preparedness and business continuity planning to prevent and manage H1N1 virus

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News